Rapid antigen testing for SARS-CoV-2 coronavirus

The Fortress COVID-19 Antigen Test, available from Una Health, is a single-use in vitro immunochromatographic assay for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab specimens.

Virus transport medium completes FDA notification process

Teknova, a manufacturer of cell culture media, protein purification buffers, and molecular biology reagents, has completed the US Food and Drug Administration (FDA) notification process for its CDC formulation Viral Transport Medium (VTM).

Local MP visits Southwest Pathology Service

Southwest Pathology Service (SPS), which has been at the forefront of the national effort to provide potentially life-saving coronavirus and COVID-19 testing, has been commended by Taunton Deane MP Rebecca Pow.

Helping diagnostic laboratories scale up liquid handling

The current pandemic has led to unparalleled pressure on laboratories to ramp up capacity for SARS-CoV-2 testing. INTEGRA’s electronic pipettes, pipetting robots and other instruments have helped many laboratories tackle this challenge.

Detection of circulating SARS-CoV-2 neutralising antibodies

The SARS-CoV-2 pandemic is one of the most urgent infectious disease challenges the world has faced in recent history. As few treatment options exist, the need to evaluate neutralising antibodies to fight the virus is at an all-time high.

New SARS-CoV-2 test provides results in 39 minutes

A rapid new coronavirus test, which provides results in just 39 minutes, is now available on the Vivalytic, a point-of-care platform brought to market by Randox Laboratories and Bosch.

Successful evaluation of PrimeStore MTM viral transport medium

EKF Diagnostics has announced that the viral transport medium PrimeStore MTM (Molecular Transport Medium) has been successfully evaluated for effective SARS-CoV-2 inactivation in a new study published by Public Health England.

Dundee biomedical scientist wins award for writing on PV testing

A Dundee-based biomedical scientist has won the 2020 Bernie Benson Prize for his science writing. The competition sought to promote the understanding and exploration of blood viscosity testing.

Contact tracing app security flaws

The CEO of a British technology company has warned the government of potential serious flaws in the security of personal information and data used in the new contact tracing app technology that was announced by Matt Hancock.

New RNase Inhibitor ensures reliable RNA protection

PCR Biosystems has launched RiboShield RNase Inhibitor, a robust and reliable RNase inhibitor that is now available as a standalone product.

Global COVID-19 long-term study launched

Researchers and clinicians in Glasgow will lead a global study into the long-term health impacts of COVID-19, and are inviting hospitals and healthcare sites worldwide to join this new initiative.

SARS-CoV-2 ELISA laboratory test launched

Avacta Group, the developer of Affimer biotherapeutics and reagents, has announced its intention to launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global research efforts into the coronavirus that causes COVID-19.

Viral transport media production scaled up in response to SARS-CoV-2

Teknova, a manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, has responded to the SARS-CoV-2 pandemic by significantly scaling up production of Viral Transport Medium (VTM) and saline.

Rapid SARS-CoV-2 antigen test manufacturing capacity expanded

Avacta Group, the developer of Affimer biotherapeutics and reagents, has entered an agreement with Abingdon Health for the manufacture of its saliva-based rapid SARS-CoV-2 antigen test as part of an ongoing expansion of manufacturing capacity.

Expanded SARS-CoV-2 testing with electrochemiluminescence immunoassay

Avero Diagnostics, a physician-owned US laboratory, has announced the expansion of its COVID-19 testing portfolio with the addition of the Roche Elecsys anti-SARS-CoV-2 antibody test.

Deployment of novel, cost-effective SARS-CoV-2 vaccine technology

Edinburgh-based biotechnology company Ingenza has made a significant breakthrough in the race to develop and manufacture a cost-effective vaccine against SARS-CoV-2, the virus responsible for the current pandemic and COVID-19 disease.

Reducing viral replication by aryl hydrocarbon receptor inhibition

Hercules Pharmaceuticals has announced the publication of promising preclinical in vivo trial results showing efficacy of its aryl hydrocarbon receptor (AhR) inhibitor HP163 against Zika virus infection and potentially against coronavirus.

Executive War College: ongoing virtual interactive sessions

Remarkable things are happening as laboratories and anatomical pathology groups answer the challenges of the SARS-CoV-2 pandemic and the need for greater numbers of virus tests. Despite shortages, laboratories are adding SARS-CoV-2 test capacity.

Molecular transport medium optimised for molecular testing

PrimeStore MTM is a molecular transport medium that provides a ‘snapshot’ in time of a sample by preserving and stabilising DNA and RNA. This means that samples can be collected, transported, and processed safely and efficiently.

Antibodies for SARS-CoV-2 virus detection

ViroStat has released a set of new monoclonal antibodies to the nucleocapsid of the SARS-CoV-2 virus. These five antibodies were selected from a group of 60 based on highest binding affinity and best ELISA pairing to detect native viral antigen.